Literature DB >> 18165923

Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.

Anna Roszkowska1, Jerzy Klimek, Krystian Kaletha.   

Abstract

Background AMP-deaminase (EC 3.5.4.6) and 5'-nucleotidase (EC 3.1.3.5) are enzymes responsible for the maintenance of cellular adenine nucleotides pool. Both exist in several isoforms that differ in kinetic properties and tissue distribution. Profile of isoforms of these enzymes in human placenta has not been analyzed so far while this could be important for understanding of pathology of placental ischemia such as in preeclampsia. Our aim was therefore to analyze expression of AMPD and CN-I genes in human term placenta. Methods RT-PCR analysis was used for determine expression of AMPD1, AMPD2, AMPD3 and CN-I. Results and conclusion The experimental results presented here indicate that genes coding "AMP-preferring", cytosolic isozyme of 5'-nucleotidase (cN-I) as well as "muscle-type" isozyme of AMP-deaminase (AMPD1) are not expressed in human term placenta. Among other AMPD family genes, only these coding "liver-type" isozyme (AMPD2) and, in lesser degree, "erythrocyte-type" isozyme (AMPD3) of AMP-deaminase are expressed in this organ. The expression level of AMPD3 was a half of that presented by AMPD2. We conclude that high abundance of AMP-deaminase 2 transcript suggest that this particular isoform is a predominant pathway of adenine nucleotides degradation in human term placenta that follows liver-type regulation of this process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165923     DOI: 10.1007/s11010-007-9699-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

1.  Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.

Authors:  S A Hunsucker; J Spychala; B S Mitchell
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

2.  AMP-deaminase from human term placenta.

Authors:  A Swieca; I Rybakowska; G Nagel-Starczynowska; E Kossowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Human liver AMP-deaminase--oligomeric forms of the enzyme.

Authors:  M Szydłowska; G Nagel-Starczynowska; I Rybakowska; A Swieca; K Kaletha
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Presence of adenosine in the human term placenta. Determination of adenosine content and pathways of adenosine metabolism.

Authors:  M K Sim; M H Maguire
Journal:  Circ Res       Date:  1972-11       Impact factor: 17.367

Review 6.  Ammonia production in muscle and other tissues: the purine nucleotide cycle.

Authors:  J M Lowenstein
Journal:  Physiol Rev       Date:  1972-04       Impact factor: 37.312

7.  AMP deaminase isozymes in human tissues.

Authors:  N Ogasawara; H Goto; Y Yamada; T Watanabe; T Asano
Journal:  Biochim Biophys Acta       Date:  1982-02-02

8.  Characterization of the human and rat myoadenylate deaminase genes.

Authors:  R L Sabina; T Morisaki; P Clarke; R Eddy; T B Shows; C C Morton; E W Holmes
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

9.  Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.

Authors:  D K Mahnke-Zizelman; R L Sabina
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

10.  Adenylate deaminase. A multigene family in humans and rats.

Authors:  T Morisaki; R L Sabina; E W Holmes
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

View more
  1 in total

1.  Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.

Authors:  Iwona M Rybakowska; Stanisław Bakuła; Krystian Kaletha
Journal:  Int J Pept Res Ther       Date:  2016-05-13       Impact factor: 1.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.